2Vander LI, Verhoef JC, van Aelst AC, et al. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials, 2001,22 : 687.
3Sato T, Shirakawe N, Nishi H, et al. Formation of a DNA/poly-galacocaine complex cocaine complex and its interaction with cells.Chen Lett, 1996,9:725-726.
5Tanina B, Susmita M, Ajay KS, et al. Preparation characterization and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm, 2002,242: 93.
6Mitra S, Gaur U, Ghosh PC, et al. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release, 2001,74 : 317.
7Futoshi S, Hiroyuki T, Hideki I, et al. In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer. Eur J Pharm Biopharm, 2002,53:57.
8Angela M, Campos D, Alejandm S, et al. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface: application to cyclosporin A. Int J Pharm, 2001,224:159.
9Davide G,Andreas BS. In vitro evaluation of polymeic excipients protecting calcitonin against degradation by intestinal serine proteases. Int J Pharm, 2003 , 252:187.
10Thanou MM, Kotze AF, Scharringhausen T, el al. Effect of degree of quaternization of N-trimethyl chlitosan chloride for enhanced transport of hydrophilic compounds across isintestinal caco2 cell monolayers. J Controlled Release,2000, 64( 1-3 ) : 15.
二级参考文献12
1Willim MP. Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems[J]. Pharm Sci Technol Today,1999:49-51
2Illum L. Transport of drugs from the nasal cavity to the central nervous system[J]. Eur J Pharm Sci,2000, 11:1-18
3Sakane T, Yamashita S, Yata H, et al. Transnasal delivery of 5-fluorouracil to the brain in the rat [J]. J Drug Target, 1999,7:233-239
4Denkbas EB, Seyyal M, Piskin E. Implantable 5-fluorouracil loaded chitosan scaffolds prepared by wet spinning[J]. J Membr Sci,2000,172:33-38
5Lim ST,Mrtin GP,Berry DJ,et al. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan[J]. J Control Release, 2000, 66:281-292
6Emad EH, Roy CP, James MG. Optimized Formulation of Magnetic Chitosan Micropheres Containing the Anticancer Agent, Oxantrazole [J]. Pharm Res,1992,9:390-397
7Tang MX,Szoka FC. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes[J]. Gene Therapy, 1994:823-832.
8Bazile D, Prud'homme C, Bassoullet MT, et al, Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system[ J]. J Pharm Sci, 1995,84:493-498.
9Biessen EA, Vietsch H, Rump ET, et al. Targeted delivery of oligoeoxynucleotides to parenchymal liver cells in vivo [ J].Biochem J, 1999,340:783-792.
10Yamasaki K, Shibata Y, Imai S, et al. Clinical applicantion of prostaglandin E1 (PGE1) upon orthodontic tooth move- ment [J]. Am J Orthod, 1984,85(6):508-518.
